Stay updated on Pembrolizumab vs Paclitaxel in Asian Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Paclitaxel in Asian Gastric Cancer Clinical Trial page.

Latest updates to the Pembrolizumab vs Paclitaxel in Asian Gastric Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe revision label was updated from Revision: v3.5.0 to Revision: v3.5.2.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe site software version was updated from v3.4.3 to v3.5.0. No changes to study content or visible features are indicated.SummaryDifference0.0%

- Check37 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. The change is limited to the page version tag and does not modify study details or content.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page now includes a new site revision tag: Revision: v3.4.2. The older funding-status notice and the earlier Revision: v3.4.1 text have been removed.SummaryDifference0.3%

- Check73 days agoChange DetectedAdded a government funding lapse notice regarding NIH site status and updated the site revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.3%

- Check80 days agoChange DetectedA new 'Show glossary' option was added to the page interface, and several metadata labels were updated (e.g., 'Last Update Submitted that Met QC Criteria', 'No FEAR Act data') with the revision note showing 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab vs Paclitaxel in Asian Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Paclitaxel in Asian Gastric Cancer Clinical Trial page.